Claims
- 1. A method of treating asthma, while reducing side effects associated with the administration of racemic albuterol, comprising administering to an individual suffering from asthma a quantity of an optically pure R(-) isomer of albuterol sufficient to result in bronchodilation while simultaneously reducing undesirable side effects, said R isomer being substantially free of its S(+) isomer.
- 2. A method according to claim 1, wherein the albuterol comprises at least 90% by weight of the R(-) isomer and not more than 10% by weight of the S(+) isomer.
- 3. A method according to claim 1, wherein the albuterol comprises at least 99% by weight of the R(-) isomer and 1% or less by weight of the S(+) isomer.
- 4. A method according to claim 1, wherein the optically pure R(-) albuterol is administered by inhalation.
- 5. A method according to claim 4, wherein the optically pure R(-) albuterol is administered in an amount of about 30 .mu.g to about 90 .mu.g.
- 6. A method according to claim 1, wherein the optically pure R(-) albuterol is administered orally.
- 7. A method according to claim 6, wherein the optically pure R(-) albuterol is administered in an amount of about 1 mg to about 8 mg.
- 8. A method according to claim 6, wherein the optically pure R(-) albuterol is administered as a syrup.
- 9. A method according to claim 7, wherein the optically pure R(-) albuterol is administered as a syrup.
Parent Case Info
This is a continuation of U.S. application Ser. No. 08/335,480, filed Nov. 7, 1994, now U.S. Pat. No. 5,547,994, which is a continuation of U.S. application Ser. No. 08/163,581 filed Dec. 7, 1993, now U.S. Pat. No. 5,362,755, which is a continuation of U.S. application Ser. No. 07/896,725, filed Jun. 9, 1992, abandoned, which is a continuation of U.S. application Ser. No. 07/461,262, filed Jan. 5, 1990, abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
5362755 |
Barberich et al. |
Nov 1994 |
|
5547994 |
Barberich et al. |
Aug 1996 |
|
Foreign Referenced Citations (3)
Number |
Date |
Country |
2128258 |
Nov 1983 |
DEX |
1298494 |
May 1971 |
GBX |
2 255 503 |
Jul 1992 |
GBX |
Non-Patent Literature Citations (11)
Entry |
Tan et al. "Stereoselective Disposition of Salbutamol Enantiomer . . . " Clin. Chem. 33, 1026 (1987). |
Brittain et al. "Some observations on the .beta.-adrenoceptor agonist . . . " Br. J. Pharmac. 48, 144-147 (1973). |
Hartley et al. "Absolute Configuration of the Optical Isomers of Salbutamol" J. Med. Chem. 12, 995 (1971). |
Hawkins et al. "Relative Potency of (-)-and (.+-.)-Salbutamol on Guinea Pig . . . " J. Med. Chem. 16, 856-857 (1973). |
Buckner et al. "Studies on the Effects of Enantiomers of Soterenol, Trimetoquinol . . . " J. Pharm. Exp. Ther. 189, 616-625 (1974). |
Passowicz-Muszynska E. "Effect on beta adrenergic receptors of tachyphylaxis . . . " Index Medicus 91:164287. |
Pauwels "Effect of cortiocosteroids on the action of sympathomimetics" Index Medicus 86:051970. |
Chapman et al. "An anomalous effect of salbutamol in sensitised guinea pigs" Brit. J. Pharmacol 99, 66P (1990). |
Morley et al. "Effects of (+) and racemic salbutamol on airway responses in the guinea pig" Brit. J. Pharmacol. 104, 295P (1991). |
Chapman et al. "Racemic mixtures at root of worsening symptom? Active enantiomers . . . " TIPS 13, 231-232 (1992). |
Muittari et al. "Comparison of acute bronchodilator effects of oral salbutamol, . . . " Chem. Abstr. 89: 123259m (1978). |
Continuations (4)
|
Number |
Date |
Country |
Parent |
335480 |
Nov 1994 |
|
Parent |
163581 |
Dec 1993 |
|
Parent |
896725 |
Jun 1992 |
|
Parent |
461262 |
Jan 1990 |
|